ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000

States Spent Only 3.2% Of Settlement Money On Smoking Cessation.

November 21, 2008

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

Program Announcements

August 3, 2001